Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

WVE
Wave Life Sciences Ltd.
stock NASDAQ

Market Open
Jul 21, 2026 3:36:50 PM EDT
5.82USD+1.658%(+0.09)655,406
5.82Bid   5.83Ask   0.01Spread
Pre-market
Jul 21, 2026 9:28:20 AM EDT
5.71USD-0.349%(-0.02)5,702
After-hours
Jul 20, 2026 4:37:30 PM EDT
5.70USD-0.697%(-0.04)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
07:23AM EST  Two Organizations To Support Wave Life Sciences' FTD, ALS Program   Benzinga
Jan 25, 2022
11:07AM EST  ADDF and AFTD Partner to Support Wave Life Sciences' FTD and ALS Clinical   PR Newswire
Dec 23, 2021
07:07PM EST  Vintage Wine Estates marks eight years and one million meals donated through   PR Newswire
Nov 11, 2021
11:55AM EST  How Good Are WAVE Life Sciences's Earnings? | Return On Capital Employed   Benzinga
Nov 10, 2021
07:39AM EST  WAVE Life Sciences Q3 EPS $(0.12) Beats $(0.63) Estimate, Sales $36.42M Up From $3.45M YoY   Benzinga
07:30AM EST  Strengthened balance sheet with approximately $52 million; focusing additional investment in RNA editing programs led by hepatic editing   GlobeNewswire Inc
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 8, 2021
04:05PM EST  Wave Life Sciences to Present at the Stifel 2021 Virtual   GlobeNewswire Inc
Nov 1, 2021
08:30AM EDT  Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at8:30 a.m. ETonWednesday, November 10, 2021, to discuss its third quarter 2021 financial results and provide a business update.   GlobeNewswire Inc
Oct 19, 2021
08:23AM EDT  The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio   Benzinga
Oct 18, 2021
05:01PM EDT  Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs   Benzinga
05:00PM EDT  Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing   GlobeNewswire Inc
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 5, 2021
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Sep 29, 2021
08:30AM EDT  Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping   GlobeNewswire Inc
07:21AM EDT  Wave Life Sciences Shows Durable ADAR-Editing In Multiple Tissues In Animal Studies   Benzinga
Sep 28, 2021
04:05PM EDT  Wave Life Sciences Announces New Data For Leading RNA Editing Capability Across Multiple Tissues, Provides Update On AATD Program During Analyst And Investor Research Webcast   Benzinga
04:05PM EDT  Durable ADAR editing in vivo in preclinical models, including in CNS tissues with editing out to at least four months   GlobeNewswire Inc
Sep 22, 2021
04:25PM EDT  Wave Life Sciences To Present At Chardan Genetic Medicines Conference Monday, Oct. 4, 2021 At 2 p.m. EDT   Benzinga
04:05PM EDT  Wave Life Sciences to Present at the Chardan Virtual Genetic   GlobeNewswire Inc
Sep 9, 2021
08:46AM EDT  Wave Life Sciences Announces Initiation Of Dosing In Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington's Disease   Benzinga
08:30AM EDT  Only clinical-stage candidate for Huntingtons disease designed to selectively lower mutant HTT and spare wild-type HTT   GlobeNewswire Inc
Sep 8, 2021
08:30AM EDT  Wave Life Sciences to Highlight RNA Editing Capability and AATD   GlobeNewswire Inc
Sep 7, 2021
04:05PM EDT  Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual   GlobeNewswire Inc
08:30AM EDT  Wave Life Sciences to Highlight RNA Editing Modality and PRISM   GlobeNewswire Inc
Sep 2, 2021
10:22AM EDT  Wave Life Sciences Sponsored Study Titled 'Study of WVE-003 in Patients With Huntington's Disease' Posted To ClinicalTrials.gov; Shows Study Is Recruiting   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
08:06AM EDT  WAVE Life Sciences Q2 EPS $(0.78) Misses $(0.64) Estimate, Sales $2.78M Down From $3.03M YoY   Benzinga
08:04AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
07:30AM EDT  Dosing underway in FOCUS-C9 clinical trial of WVE-004 in C9-ALS / C9-FTD first oligonucleotide using PN backbone chemistry modifications in clinical study   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 26, 2021
04:05PM EDT  Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at8:30 a.m. ETonThursday, August 5, 2021, to discuss its second quarter 2021 financial results and provide a business update.   GlobeNewswire Inc
Jul 20, 2021
08:01AM EDT  Wave Life Sciences Announces Initiation Of Dosing in Phase 1b/2a FOCUS-C9 Clinical Trial Of WVE-004 In Amyotrophic Lateral Sclerosis And Frontotemporal Dementia   Benzinga
08:00AM EDT  First clinical dosing of a compound using PN backbone chemistry modifications   GlobeNewswire Inc
Jun 3, 2021
08:23AM EDT  The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout   Benzinga
08:10AM EDT  Wave Life Sciences' RNA Editing Platform Shows Restoration of Functional AAT Protein in Preclinical Study   Benzinga
Jun 2, 2021
04:53PM EDT  Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency   Benzinga
04:52PM EDT  First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency   GlobeNewswire Inc
May 28, 2021
08:39AM EDT  WAVE Life Sciences National Institutes For Health ClinicalTrials.gov Study Record For Co.'s 'Open-label Phase 1b/2a Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy,' Shows Not Yet Recruiting   Benzinga
08:30AM EDT  Wave Life Sciences to Present at Jefferies Virtual Healthcare   GlobeNewswire Inc
May 13, 2021
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
07:41AM EDT  Recap: WAVE Life Sciences Q1 Earnings   Benzinga
07:33AM EDT  WAVE Life Sciences Q1 EPS $(0.86) Misses $(0.59) Estimate   Benzinga
07:30AM EDT  Clinical trials underway with next-generation candidates incorporating PN chemistry   GlobeNewswire Inc
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 10, 2021
04:05PM EDT  Wave Life Sciences to Present at RBC Capital Markets Global   GlobeNewswire Inc
May 3, 2021
04:05PM EDT  Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at8:30 a.m. ETonThursday, May 13, 2021, to discuss its first quarter 2021 financial results and provide a business update.   GlobeNewswire Inc
Apr 9, 2021
01:34PM EDT  Deerfield Management In 13G Filing Discloses 7.98% Stake In Wave Life Sciences   Benzinga
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 30, 2021
02:33PM EDT  Mid-Afternoon Market Update: Crude Oil Down 1.5%; Performant Financial Shares Spike Higher   Benzinga
12:26PM EDT  Mid-Day Market Update: VirTra Jumps Following Q4 Results; Wave Life Sciences Shares Slide   Benzinga
10:19AM EDT  Mid-Morning Market Update: Markets Open Lower; McCormick Profit Tops Views   Benzinga
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
07:12AM EDT  SVB Leerink Reiterates Market Perform on WAVE Life Sciences, Lowers Price Target to $7   Benzinga
05:38AM EDT  Wave Life Sciences Stock Plunges After Antisense Oligonucleotide Candidates Disappoint In Huntington's Disease Study   Benzinga
Mar 29, 2021
04:14PM EDT  Wave Life Sciences Says mHTT Results From PRECISION-HD Trials Do Not Support Further Development Of WVE-120102 And WVE-120101   Benzinga
04:05PM EDT  mHTT results from PRECISION-HD trials do not support further development of WVE-120102 and WVE-120101   GlobeNewswire Inc
Mar 27, 2021
01:01PM EDT  The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week   Benzinga
Mar 19, 2021
08:00AM EDT  Wave Life Sciences to Present at the Third Annual Stifel CNS Day   GlobeNewswire Inc
Mar 4, 2021
10:25AM EST  Looking Into WAVE Life Sciences's Return On Capital Employed   Benzinga
10:13AM EST  WAVE Life Sciences shares were trading higher after the company reported better-than-expected Q4 EPS results.   Benzinga
07:24AM EST  WAVE Life Sciences Q4 EPS $(0.59) Beats $(0.61) Estimate, Sales $9.44M Miss $9.75M Estimate   Benzinga
07:20AM EST  WAVE Life Sciences: Q4 Earnings Insights   Benzinga
07:00AM EST  Strong execution in 2020 sets stage for advancing five clinical programs and novel ADAR editing modality in 2021   GlobeNewswire Inc
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Feb 23, 2021
08:00AM EST  Wave Life Sciences to Webcast Conference Call of Fourth Quarter   GlobeNewswire Inc
Feb 16, 2021
05:00PM EST  Wave Life Sciences to Present at the 10th Annual SVB Leerink   GlobeNewswire Inc
Jan 11, 2021
08:02AM EST  Wave Life Sciences Highlights Pipeline Progress, Expansion Leveraging New PN Backbone Chemistry Modifications   Benzinga
08:00AM EST  Three clinical trials to begin in 2021 with compounds containing Waves novel PN backbone chemistry modifications   GlobeNewswire Inc
Dec 15, 2020
06:15AM EST  HC Wainwright & Co. Assumes WAVE Life Sciences at Buy, Announces Price Target of $20   Benzinga
Dec 2, 2020
08:00AM EST  Wave Life Sciences Announces Appointment of Jonathan Rosin as   GlobeNewswire Inc
Nov 10, 2020
08:00AM EST  Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 29th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 2020 at 5:00 p.m. ET.   GlobeNewswire Inc
Nov 9, 2020
11:33AM EST  WAVE Life Sciences shares were trading lower after the company reported worse-than-expected Q3 EPS and sales results.   Benzinga
08:14AM EST  WAVE Life Sciences: Q3 Earnings Insights   Benzinga
07:38AM EST  WAVE Life Sciences Q3 EPS $(0.86) Misses $(0.69) Estimate, Sales $3.45M Miss $11.55M Estimate   Benzinga
07:30AM EST  Resultsfrom all cohorts ofPRECISION-HD1 and PRECISION-HD2 clinical trials and initial OLEdataon track for 1Q 2021   GlobeNewswire Inc
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Oct 26, 2020
04:05PM EDT  Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Monday, November 9, 2020, to discuss its third quarter 2020 financial results and provide a business update.   GlobeNewswire Inc
Oct 23, 2020
10:48AM EDT  Benzinga's Top Upgrades, Downgrades For October 23, 2020   Benzinga
06:29AM EDT  RBC Capital Initiates Coverage On WAVE Life Sciences with Sector Perform Rating, Announces Price Target of $13   Benzinga
Sep 28, 2020
04:05PM EDT  Wave Life Sciences to Present at the Chardan Virtual 4th Annual   GlobeNewswire Inc
Sep 23, 2020
02:57PM EDT  Mid-Afternoon Market Update: Dow Tumbles 400 Points; JinkoSolar Shares Jump   Benzinga
12:20PM EDT  Mid-Day Market Update: Gold Falls 2%; SPI Energy Shares Spike Higher   Benzinga
11:29AM EDT  Mid-Morning Market Update: Markets Mixed; General Mills Beats Q1 Estimates   Benzinga
10:33AM EDT  Shares of clinical stage genetic medicine company, Wave Life Sciences Ltd. (WVE) are falling more than 32% Wednesday morning at $10.70. The stock has been trading in the range of $6.61- $39.98 in the past one year.   RTTNews
10:11AM EDT  Mid-Morning Market Update: Markets Mixed; General Mills Beats Q1 Estimates   Benzinga
07:05AM EDT  Wave Life Sciences Prices ~8.33M Share Offering At $12/Share   Benzinga
07:00AM EDT  Wave Life Sciences Prices $100 Million Public Offering of Ordinary   GlobeNewswire Inc
Sep 22, 2020
06:28PM EDT  Beazer Homes USA, Inc. (BZH) - Shares of the homebuilder gained 9% in after-hours trading Tuesday after the company reported improvement in new orders for the first two months of the fourth quarter. Net new orders for the first two months of fourth quarter were up 37% year-over-year with a 26% increase in July and a 48% increase in August.   RTTNews
04:34PM EDT  Hearing Wave Life Sciences Shares To Be Offered At $12/Share   Benzinga
04:01PM EDT  Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares; No Terms Disclosed   Benzinga
04:01PM EDT  Wave Life Sciences Announces Proposed Public Offering of Ordinary   GlobeNewswire Inc
Sep 15, 2020
07:30AM EDT  Wave Life Sciences to Highlight Preclinical ADAR Editing Data and   GlobeNewswire Inc
Sep 10, 2020
04:25PM EDT  Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual   GlobeNewswire Inc
Aug 10, 2020
08:11AM EDT  WAVE Life Sciences: Q2 Earnings Insights   Benzinga
07:59AM EDT  WAVE Life Sciences Q2 EPS $(1.15) Misses $(0.97) Estimate, Sales $3.03M Miss $5.65M Estimate   Benzinga
07:42AM EDT  Data from 32 mg cohorts of both PRECISION-HD trials and PRECISION-HD OLE trials expected in 1Q 2021   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Aug 6, 2020
08:00AM EDT  Neurology pipeline discussion will include new preclinical data for C9orf72 program for ALS and FTD   GlobeNewswire Inc
Jul 27, 2020
04:05PM EDT  Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Monday, August 10, 2020, to discuss its second quarter 2020 financial results and provide a business update.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC